References
- 1. ORRICO K., Basic concepts in genetics and pharmacogenomics for pharmacists, Drug Target Insights, 2019, doi: 10.1177/1177392819886875.
- 2. 2019, Table of pharmocaogenomic Biomarkers in Drug Labelling. FDA. Viewed: 12/11/2019, https://www.fda.gov/Drugs/ScienceResearch/ucm572698.htm.
- 3. MAREZ D., LEGRAND M., SABBAGH N., LO GUIDICE J.M., SPIRE C., LAFITTE J.J. et al., Polymorphism of the cytochrome P450 CYP2D6 in a European population: Characterization of 48 mutations of 53 alleles, their frequencies and evolution, Pharmacogenetics, 1997, 7(3): 193.
- 4. KELLY L., RIEDER M., VAN DEN ANKER J., MALKIN B., ROSS C., NEELY M.N. et al., More codeine fatalities after tonsillectomy in North American children, Pediatrics, 2012, 129(5).
- 5. GOETZ M., SANGKUHL K., GUCHELAAR H.J., SCHWAB M., PROVINCE M., WHIRL-CARRILLO M. et al., Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and tamoxifen therapy, Clin. Pharmacol. Ther., 2018, 103(5):770–777.
- 6. RAY S., Clopidogrel resistance: The way forward, Indian heart journal, 2014, 66(5):530–534.
- 7. RUSH A.J., FAVA M., WISNIEWSKI S.R., LAVORI P.W., TRIVEDI M.H., SACKEIM H.A. et al., Sequenced Treatment Alternatives to Relieve Depression. Control clin trials, 2004, 25(1):119–142.
- 8. EVANS W.E., HON Y.Y., BOMGAARS L., COUTRE S., HOLDSWORTH M., JANCO R. et al., Preponderance of thiopurine S-methyltransferase deficiency and heterozygosity among patients intolerant to mercaptopurine or azathioprine, Journal of Clinical Oncology, 2001, 19(8):2293–2301.
- 9. RELLING M. et al., Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2018 update, CIPC update, 2018.
- 10. BRUNHAM L. et al., Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence, Cardiovasc. Res., 2018, 114(8):1073.
- 11. TARAVES L. et al., Genotype-guided warfarin therapy: The current status, Pharmacogenomics, 2018, 19(7):667–685.
- 12. 2019, Direct-To-Consumer Testing. FDA. Viewed: 12/25/2019 https://www.fda.gov/medical-devices/vitro-diagnostics/direct-consumer-tests#list
- 13. SHAH R., SMITH R., Addressing phenoconversion: The Achillies’ heel of personalised medicine, Brit. J. Clin. Pharmacol., 2015, 79(2):222–240.